This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, Y.-L. Articles by Lee, Y.-C. Search for Related Content PubMed PubMed Citation Articles by Chang, Y.-L. Articles by Lee, Y.-C.

Clonality and Prognostic Implications of p53 and Epidermal Growth Factor Receptor Somatic Aberrations in Multiple Primary Lung Cancers

Authors' Affiliations: Departments of ¹ Pathology and ² Surgery and Traumatology, National Taiwan University Hospital and National Taiwan University College of Medicine; ³ Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; and ⁴ Division of Biostatistics and Bioinformatics, National Health Research Institute, Miaoli, Taiwan

Requests for reprints: Yung-Chie Lee, Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, 6F-1, 99, Section 3, Roosevelt Road, Taipei 10646, Taiwan. Phone: 886-2-23625177; Fax: 886-2-23625176; E-mail: damu{at}ha.mc.ntu.edu.tw or Yuh-Shan Jou, Institute of Biomedical Sciences, Academia Sinica, 128, Yen-Chiu-Yuan Road, Taipei 11529, Taiwan. E-mail: jou{at}ibms.sinica.edu.tw.

Purpose: For treatment decision and prognostic applications, we evaluated p53/epidermal growth factor receptor (EGFR) somatic aberrations in multiple primary lung cancers to differentiate multifocal tumors from intrapulmonary metastasis.

Experimental Design: Fifty-eight multiple primary lung cancers of 1,037 patients in a 10-year period were identified to investigate somatic mutations and altered expression of p53 and EGFR for clonality assessment. Genomic DNA was extracted from microdissected cells of paraffin-embedded multiple primary lung cancer tissues. Overexpression and somatic mutations in exons of p53 (exons 5-8) and tyrosine kinase domain of EGFR (exons 18-22) were examined by immunohistochemical staining and DNA sequencing, respectively.

Results: High frequency of somatic mutations in p53 (33 of 58, 56.9%) and/or EGFR (44 of 58, 75.9%) resulted in high discrimination rate of tumor clonality (50 of 58, 86.2%) of multiple primary lung cancers. Twenty-two cases (37.9%) were assessed as having the same clonality and 28 cases (48.3%) were determined as having different clonality, which further supported the carcinogenic theory of field cancerization. Notably, the occurrence of lymph node metastasis was more commonly observed in tumors with the same clonality (P = 0.045) and was associated with poor patient 5-year survival rate (P = 0.001). However, no correlation was found between tumor clonality and patient survival (P = 0.630). The EGFR somatic aberrations in 58 multiple primary lung cancers, including vascular invasion associated with EGFR overexpression (P = 0.012) and mutation (P = 0.025), further suggested the potential benefits of target therapy of inoperable multiple primary lung cancers.

Conclusions: Our results suggest that analysis of somatic alterations in p53 and EGFR can significantly improve the clonality assessment and impact management of multiple primary lung cancer patients.

This article has been cited by other articles:

				X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF]

				C. Verri, L. Roz, D. Conte, T. Liloglou, A. Livio, A. Vesin, A. Fabbri, F. Andriani, C. Brambilla, L. Tavecchio, et al. Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 396 - 401. [Abstract] [Full Text] [PDF]

				P. De Leyn, J. Moons, J. Vansteenkiste, E. Verbeken, D. Van Raemdonck, P. Nafteux, H. Decaluwe, and T. Lerut Survival after resection of synchronous bilateral lung cancer Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1215 - 1222. [Abstract] [Full Text] [PDF]

				K. Steiling, J. Ryan, J. S. Brody, and A. Spira The Field of Tissue Injury in the Lung and Airway Cancer Prevention Research, November 1, 2008; 1(6): 396 - 403. [Abstract] [Full Text] [PDF]

				I. Orlow, B. J. Park, U. Mujumdar, H. Patel, P. Siu-Lau, B. A. Clas, R. Downey, R. Flores, M. Bains, N. Rizk, et al. DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors J. Clin. Oncol., July 20, 2008; 26(21): 3560 - 3566. [Abstract] [Full Text] [PDF]

				Y.-L. Chang, C.-T. Wu, and Y.-C. Lee Surgical treatment of synchronous multiple primary lung cancers: Experience of 92 patients J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 630 - 637. [Abstract] [Full Text] [PDF]